Brachytherapy seed manufacturer Theragenics has finalized a three-year agreement to provide worldwide brachytherapy loading services to cancer treatment product company Oncura, a unit of GE Healthcare.
Under the terms of the agreement, Theragenics will load and package iodine-125 brachytherapy seeds manufactured by Oncura in prescription-loaded needles, custom strands, and other configurations. Theragenics has been Oncura's exclusive palladium-103 brachytherapy seed supplier since December 2009, providing TheraSeed for Oncura in prescription-loaded and custom-stranded configurations.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
